Cancer drugs spared funding axe following appeals

By Nick Renaud-Komiya2015-03-13T13:07:00

Source: Evgeny Rannev

Three drugs that NHS England said would be axed from the cancer drugs fund will remain available at least temporarily, following a series of appeals by drug companies.

You need to be a subscriber to read more

Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

All HSJ news by sector, topic & region
Breaking News announcements
App for mobile and offline reading
Comment and Daily Insights newsletters
Regional roundup newsletters
Unrestricted access to ‘Ask HSJ’ - AI assistant - AI assistant
10 expert briefings every fortnight (Premium only)

to HSJ

Already a subscriber? Sign into your account here